InvestorsHub Logo
Followers 49
Posts 4107
Boards Moderated 0
Alias Born 02/15/2009

Re: None

Tuesday, 11/05/2013 8:07:19 AM

Tuesday, November 05, 2013 8:07:19 AM

Post# of 2504
From today's PR: "SEAMLESS, our pivotal Phase 3 trial in front-line elderly AML, the primary outcome in our Phase 2 study of sapacitabine in MDS after front-line treatment failure"
Does this mean that sapacitabine failed the trial?
Thanks!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYCC News